editorial | Q871232 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0025-6196(12)61354-8 |
P698 | PubMed publication ID | 8015338 |
P2093 | author name string | G J Gleich | |
A N Mayeno | |||
P2860 | cites work | Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome | Q28268913 |
An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. | Q34036919 | ||
A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan). | Q34138191 | ||
L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. | Q34264077 | ||
The eosinophilia-myalgia syndrome and tryptophan | Q35706242 | ||
L-tryptophan and eosinophilia-myalgia syndrome in New Mexico | Q37582090 | ||
Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome | Q40745141 | ||
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan | Q40763876 | ||
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? | Q41888532 | ||
3-anilino-L-alanine, structural determination of UV-5, a contaminant in EMS-associated L-tryptophan samples | Q45198230 | ||
P433 | issue | 7 | |
P921 | main subject | Germany | Q183 |
eosinophilia-myalgia syndrome | Q3508806 | ||
P304 | page(s) | 702-704 | |
P577 | publication date | 1994-07-01 | |
P1433 | published in | Mayo Clin Proc | Q6538184 |
P1476 | title | The eosinophilia-myalgia syndrome: lessons from Germany | |
P478 | volume | 69 |